Dental Oral infectious and inflammatory diseases are the most common human diseases worldwide and cause significant morbidity, impacting upon general health, wellbeing and mortality rates, Periodontal Research ,Oral Diseases, Dental and Craniofacial Stem Cell Biology, Dental and Biomaterials science, Phototherapy, Clinical Epidemiology and Dental Public Health. Their impact on the economy is substantial. Our research is making significant inroads into understanding their pathobiology and translating this into novel treatments.
Oral cancer is currently the 6th most common form of cancer with survival rates of only 60% and we aim to impact significantly upon these statistics through our collaborative research activities. Our interdisciplinary research excellence in the field of tissue repair, regeneration and rehabilitation draws upon multi-disciplinary expertise to improve current, and develop future, therapeutic solutions.
Theclinical-basic science partnerships provide broad expertise and enable us to exploit our findings through clinical trials of novel diagnostics and therapeutics. While our state-of-the-art purpose built laboratories and associated clinics house cutting-edge technologies enabling us to explore disease mechanisms, improve our understanding of pathogenic processes, and formulate new healthcare solutions.
The strengths is internationally-leading teams centre on developing a sound understanding of disease mechanisms to underpin novel diagnostic, tissue regenerative and engineering therapeutic strategies for periodontal diseases, caries and oral cancer; and are enhanced by strong local, global collaborations. Our focus on the scientific basis of oral and dental disease is providing innovative solutions to important problems significantly impacting the population and is helping us to deliver our vision for improving oral and general health system.